Table 2 Patient Characteristics
Variable | N = 60 (100%) |
|---|---|
Age | |
 Median | 59 years |
 Range | 29 to 70 years |
Gender | |
 Male | 42 (70%) |
 Female | 18 (30% |
Race/Ethnicity | |
 Asian | 1 (1.7%) |
 Black | 2 (3.3%) |
 Hispanic | 10 (17%) |
 Other | 3 (5.0%) |
 White | 43 (72%) |
KPS at baseline | |
 70 | 14 (23%) |
 80 | 17 (28%) |
 90 | 25 (42%) |
 100 | 4 (7%) |
MGMT promoter status | |
 Methylated | 20 (33%) |
 Unmethylated | 39 (65%) |
 Equivocal | 1 (2%) |
IDH1/2 genes | |
 Mutated | 7 (12%) |
 Not Mutated | 53 (88%) |
Anatomic Location of Tumor | |
 Frontal | Left 11 (18%), Right 5 (8.3%) |
 Parietal | Left 6 (10%), Right 8 (13%) |
 Temporal | Left 7 (12%), Right 13 (22%) |
 Occipital | Left 2 (3.3%), Right 1 (1.7%) |
 Fronto-Temporal | Left 0 (0%), Right 1 (1.7%) |
 Parieto-Occipital | Left 1 (1.7%) Right 0 (0%) |
 Temporo-Occipital | Left 0 (0%) Right 1 (1.7%) |
 Temporo-parieto-occipital | Left 1 (1.7%), Right 0 (0%) |
 Temporal and Amygdala | Left 0 (0%), Right 1 (1.7%) |
 Insula | Left 1 (1.7%), Right 0 (0%) |
 Corpus callosum | Left 1 (1.7%), Right 0 (0%) |